Zhongren Xu

机构：Nanjing University of Chinese Medicine · ORCID：0000-0002-3419-390X

发表论文 21 篇 · 总被引 723 次 · h-index 12

代表论文

• Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma (2022 · Redox Biology · 被引 150)
• Pt(II)-NHC Complex Induces ROS-ERS-Related DAMP Balance to Harness Immunogenic Cell Death in Hepatocellular Carcinoma (2022 · Journal of Medicinal Chemistry · 被引 80)
• Advances in alkynyl gold complexes for use as potential anticancer agents (2020 · Coordination Chemistry Reviews · 被引 76)
• Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics (2022 · Drug Discovery Today · 被引 75)
• A Gold(I) Complex Containing an Oleanolic Acid Derivative as a Potential Anti‐Ovarian‐Cancer Agent by Inhibiting TrxR and Activating ROS‐Mediated ERS (2020 · Chemistry - A European Journal · 被引 65)
• Simultaneous Activation of Immunogenic Cell Death and cGAS-STING Pathway by Liver- and Mitochondria-Targeted Gold(I) Complexes for Chemoimmunotherapy of Hepatocellular Carcinoma (2024 · Journal of Medicinal Chemistry · 被引 58)